The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Shi, Yang ^a,b,c   Liu, Can ^b   Liu, Xin ^b   Tang, Dean G ^b,c   Wang, Junchen ^a,c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c Key Laboratory of Arrhythmias of Ministry of Education   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; HERMES ANTIGEN; LENTIVIRUS VECTOR; MICRORNA 34A; OLIGONUCLEOTIDE; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MICRORNA; MIRN34 MICRORNA, HUMAN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CANCER RECURRENCE; CANCER STEM CELL; CELL CLONING; CELL EXPANSION; CELL STRAIN; CELL STRAIN A549; CELL STRAIN H1299; CELL STRAIN H460; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SYNTHESIS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; RNA PURIFICATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL CLONE; CELL PROLIFERATION; FLOW CYTOMETRY; GENETICS; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CLONE CELLS; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MICE, INBRED NOD; MICE, SCID; MICRORNAS; NEOPLASTIC STEM CELLS; PEPTIDES;

EID: 84897042607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090022     Document Type: Article

References (34)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
2. Sell S (2010) On the Stem Cell Origin of Cancer. Am J Pathol 176: 2584-2594.
3. Dean G. Tang (2012) Understanding cancer stem cell heterogeneity and plasticity. Cell Research 22: 457-472.
4. Garofalo M, Croce CM (2011) MicroRNAs: Master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol 51: 25-43.
5. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524. (Pubitemid 43345317)
6. Kasinski AL, Slack FJ. (2011) MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864.
7. Croce CM, Calin GA (2005) miRNAs, cancer, and stem cell division. Cell 122: 6-7. (Pubitemid 40977933)
8. Fei Chen, Shen-Jiang Hu (2012) Effect of MicroRNA-34a in Cell Cycle, Differentiation, and Apoptosis: A Review. J Biochem Mol Toxicol 26: 79-86.
9. Yang S, Li Y, Gao J, Zhang T, Li S, et al. (2012) MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene, doi:10.1038/onc.2012.432
10. Can Liu, Dean G. Tang (2011) MicroRNA Regulation of Cancer Stem Cells. Cancer Res 71: 5950-5954.
11. Yan K, Gao J, Yang T, Ma Q, Qiu X, et al. (2012) MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo. PLoS ONE 7: e33778.
12. Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, et al. (2010) Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70: 5923-5930.
13. Nora Bandi and Erik Vassella (2011) miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Molecular Cancer 10: 55.
14. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514. (Pubitemid 351267301)
15. Dovey JS, Zacharek SJ, Kim CF, Lees JA (2008) Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci 105: 11857-11862.
16. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833. (Pubitemid 46910191)
17. Shi Y, Fu X, Hua Y, Han Y, Lu Y, et al. (2012) The Side Population in Human Lung Cancer Cell Line NCI-H460 Is Enriched in Stem-Like Cancer Cells. PLoS ONE 7: e33358.
18. Das B, Tsuchida R, Malkin D, Koren G, Baruchel S, et al. (2008) Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 26: 1818-1830.
19. Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, et al. (2010) Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 5: e14062.
20. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, et al. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature medicine 17: 211-215.
21. Liu C, Kelnar K, Vlassov AV, Brown D, Wang J, et al. (2012) Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 72: 3393-3404.
22. Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG (2008) PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 68: 1820-1825. (Pubitemid 351416567)
23. Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, et al. (2010) Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 70: 9937-9948.
24. Martino MT Di, Leone E, Amodio N, Foresta U, Lionetti M, et al. (2012) Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence. Clin Cancer Res 18: 6260-6270.
25. Kumar B, Yadav A, Lang J, Teknos TN, Kumar P (2012) Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS One 7: e37601.
26. Li L, Yuan L, Luo J, Gao J, Guo J, et al. (2013) MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 13: 109-117.
27. Duan W, Xu Y, Dong Y, Cao L, Tong J, et al. (2013) Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway. J Radiat Res. 54: 611-619.
28. Pang RT, Leung CO, Lee CL, Lam KK, Ye TM, et al. (2013) MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1. BMC Cancer 13: 25.
29. Welch C, Chen Y, Stallings RL (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017.
30. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7: 2591-2600.
31. Wang X, Dong K, Gao P, Long M, Lin F, et al. (2013) microRNA-34a Sensitizes Lung Cancer Cell Lines to DDP Treatment Independent of p53 Status. Cancer Biother Radiopharm 28: 45-50.
32. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, et al. (2007) P53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298-1307. (Pubitemid 47176893)
33. Zhao H, Ma B, Wang Y, Han T, Zheng L, et al. (2013) MiR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Oncol Rep 29: 1027-1036.
34. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.